Quezon lawmaker in hot water for getting vaccine jab as ‘substitute’ for doctor-son

By: Krissy Aguilar - Reporter / @KAguilarINQ - Inquirer.net | March 04,2021 - 12:09 PM

Quezon Rep. Angelina “Helen” Tan, chair of the House committee on health. Screengrab from the HOR livestream

MANILA, Philippines — Government is mounting a probe on a member of the House of Representatives who had been among the first recipients of the coronavirus vaccine that was reserved for health care workers.

Vaccine czar Carlito Galvez Jr. said Quezon Rep. Angelina “Helen” Tan, who sits as chair of the House committee on health, will be subject to an investigation on allegations that she had received a Sinovac vaccine shot as a substitute for her eldest son who was said to be a doctor at the Veterans Memorial Medical Center (VMMC).

Tan, the first among lawmakers to get inoculated with the vaccine, claimed she was inoculated with the dose intended for her son as a surgeon at the said hospital.

Galvez, however, said that the mandate was clear to prioritize frontliners in the health sector in the vaccination, and that there was no directive from the national government that allows the substitution.

“Wala pong directive na gano’n, mali po iyon. Lahat ng 1.7 [million] na frontliners muna sa ngayon. Wala po munang mga dependent. We are protecting the institutions. Kulang po tayo,” Galvez said in an interview over dzBB, when sought to comment on Tan’s vaccination.

“Mali po iyon, we will investigate on that just in case meron pong nangyaring ganon,” he added.

EDV

Subscribe to our regional newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: Carlito Galvez Jr, House of Representatives, member, PROBE, vaccine czar

Subscribe to our regional newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.